Revenue ($USD): $2,216,555,000
Revenue (foreign currencies): CHF2,321,000,000
R&D spend: not available
Employees: 10,400
Fiscal year end: 12/31/22
CEO: Guillaume Daniellot
In May, Straumann announced the full acquisition of GalvoSurge, a Swiss medical device manufacturer in the dental field with a specialization in implant care and maintenance solutions.–CN